NZ598540A - Diagnostic composition comprising plasma cations having superior safety profile - Google Patents
Diagnostic composition comprising plasma cations having superior safety profileInfo
- Publication number
- NZ598540A NZ598540A NZ598540A NZ59854010A NZ598540A NZ 598540 A NZ598540 A NZ 598540A NZ 598540 A NZ598540 A NZ 598540A NZ 59854010 A NZ59854010 A NZ 59854010A NZ 598540 A NZ598540 A NZ 598540A
- Authority
- NZ
- New Zealand
- Prior art keywords
- diagnostic composition
- compound
- safety profile
- superior safety
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09174413 | 2009-10-29 | ||
| PCT/EP2010/066351 WO2011051387A1 (en) | 2009-10-29 | 2010-10-28 | Diagnostic composition comprising plasma cations having superior safety profile |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ598540A true NZ598540A (en) | 2014-03-28 |
Family
ID=43503035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ598540A NZ598540A (en) | 2009-10-29 | 2010-10-28 | Diagnostic composition comprising plasma cations having superior safety profile |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8815210B2 (enExample) |
| EP (1) | EP2493511B1 (enExample) |
| JP (1) | JP5335147B2 (enExample) |
| KR (1) | KR101545045B1 (enExample) |
| CN (1) | CN102596257B (enExample) |
| AU (1) | AU2010311478B2 (enExample) |
| BR (1) | BR112012009859B1 (enExample) |
| CA (1) | CA2773685C (enExample) |
| CO (1) | CO6531477A2 (enExample) |
| DK (1) | DK2493511T3 (enExample) |
| ES (1) | ES2435299T3 (enExample) |
| HR (1) | HRP20130991T1 (enExample) |
| IL (1) | IL218456A (enExample) |
| IN (1) | IN2012DN02126A (enExample) |
| MX (1) | MX2012005021A (enExample) |
| NZ (1) | NZ598540A (enExample) |
| PL (1) | PL2493511T3 (enExample) |
| PT (1) | PT2493511E (enExample) |
| RU (1) | RU2544113C2 (enExample) |
| WO (1) | WO2011051387A1 (enExample) |
| ZA (1) | ZA201203505B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO333914B1 (no) * | 2011-12-21 | 2013-10-21 | Ge Healthcare As | Stabilisering av diagnostisk røntgensammensetning |
| CN107982550A (zh) * | 2012-01-11 | 2018-05-04 | 通用电气医疗集团股份有限公司 | 具有低碘浓度的x-射线成像造影介质和x-射线成像方法 |
| WO2014158965A1 (en) * | 2013-03-27 | 2014-10-02 | Ge Healthcare As | Method and reagent for preparing a diagnostic composition |
| US10575744B2 (en) | 2017-02-24 | 2020-03-03 | Medtronic Cryocath Lp | Pericardial balloon mapping |
| CN109876157B (zh) * | 2019-02-27 | 2020-12-15 | 浙江大学 | 离子特异性滤膜/介孔硅的复合材料、纳米传感器及其产品和应用 |
| CN120114620B (zh) * | 2025-03-18 | 2025-12-09 | 海南普利制药股份有限公司 | 一种碘帕醇注射液及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE20733T1 (de) * | 1982-11-08 | 1986-08-15 | Nyegaard & Co As | Roentgenkontrastmittel. |
| GB8906130D0 (en) * | 1989-03-17 | 1989-05-04 | Nycomed As | Compositions |
| GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
| DE4344464A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kaskadenpolymere mit Iodaromaten |
| GB9419203D0 (en) * | 1994-09-23 | 1994-11-09 | Nycomed Innovation Ab | Contrast media |
| US8066970B2 (en) * | 2006-05-11 | 2011-11-29 | Ge Healthcare As | Contrast agents |
| BRPI0814811A2 (pt) | 2007-07-12 | 2015-02-03 | Ge Healthcare As | Composto, agente, método, e composição de diagnóstico, uso de um composto, e, método de formação de imagem |
-
2010
- 2010-10-28 IN IN2126DEN2012 patent/IN2012DN02126A/en unknown
- 2010-10-28 WO PCT/EP2010/066351 patent/WO2011051387A1/en not_active Ceased
- 2010-10-28 MX MX2012005021A patent/MX2012005021A/es active IP Right Grant
- 2010-10-28 PL PL10771120T patent/PL2493511T3/pl unknown
- 2010-10-28 BR BR112012009859A patent/BR112012009859B1/pt not_active IP Right Cessation
- 2010-10-28 HR HRP20130991AT patent/HRP20130991T1/hr unknown
- 2010-10-28 CA CA2773685A patent/CA2773685C/en not_active Expired - Fee Related
- 2010-10-28 RU RU2012116882/15A patent/RU2544113C2/ru not_active IP Right Cessation
- 2010-10-28 AU AU2010311478A patent/AU2010311478B2/en not_active Ceased
- 2010-10-28 EP EP10771120.2A patent/EP2493511B1/en not_active Not-in-force
- 2010-10-28 JP JP2012535827A patent/JP5335147B2/ja not_active Expired - Fee Related
- 2010-10-28 NZ NZ598540A patent/NZ598540A/en not_active IP Right Cessation
- 2010-10-28 US US13/497,641 patent/US8815210B2/en not_active Expired - Fee Related
- 2010-10-28 CN CN2010800498286A patent/CN102596257B/zh not_active Expired - Fee Related
- 2010-10-28 PT PT107711202T patent/PT2493511E/pt unknown
- 2010-10-28 KR KR1020127010930A patent/KR101545045B1/ko not_active Expired - Fee Related
- 2010-10-28 DK DK10771120.2T patent/DK2493511T3/da active
- 2010-10-28 ES ES10771120T patent/ES2435299T3/es active Active
-
2012
- 2012-03-04 IL IL218456A patent/IL218456A/en not_active IP Right Cessation
- 2012-04-25 CO CO12068011A patent/CO6531477A2/es unknown
- 2012-05-14 ZA ZA2012/03505A patent/ZA201203505B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120091149A (ko) | 2012-08-17 |
| RU2012116882A (ru) | 2013-12-10 |
| BR112012009859A2 (pt) | 2016-08-30 |
| ES2435299T3 (es) | 2013-12-18 |
| IL218456A (en) | 2015-08-31 |
| PT2493511E (pt) | 2013-11-18 |
| US20120328522A1 (en) | 2012-12-27 |
| RU2544113C2 (ru) | 2015-03-10 |
| JP2013509378A (ja) | 2013-03-14 |
| JP5335147B2 (ja) | 2013-11-06 |
| EP2493511B1 (en) | 2013-10-16 |
| CN102596257B (zh) | 2013-08-21 |
| CA2773685A1 (en) | 2011-05-05 |
| ZA201203505B (en) | 2013-01-31 |
| DK2493511T3 (da) | 2013-11-25 |
| KR101545045B1 (ko) | 2015-08-17 |
| IN2012DN02126A (enExample) | 2015-08-21 |
| MX2012005021A (es) | 2012-06-19 |
| IL218456A0 (en) | 2012-04-30 |
| CN102596257A (zh) | 2012-07-18 |
| US8815210B2 (en) | 2014-08-26 |
| BR112012009859B1 (pt) | 2019-10-22 |
| CA2773685C (en) | 2016-05-31 |
| EP2493511A1 (en) | 2012-09-05 |
| WO2011051387A1 (en) | 2011-05-05 |
| CO6531477A2 (es) | 2012-09-28 |
| HRP20130991T1 (hr) | 2013-12-20 |
| AU2010311478B2 (en) | 2015-09-24 |
| PL2493511T3 (pl) | 2014-05-30 |
| AU2010311478A1 (en) | 2012-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ598540A (en) | Diagnostic composition comprising plasma cations having superior safety profile | |
| AR075423A1 (es) | Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos | |
| MX2010003884A (es) | Anticuerpo dirigido a la proteina lecitina similar a inmunoglobulina de union a acido sialico-15 relacionado con osteoclastos. | |
| TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
| EA201290026A1 (ru) | Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid) | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| IN2012MN02923A (enExample) | ||
| TNSN07341A1 (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
| SG149895A1 (en) | Contrast agents for myocardial perfusion imaging | |
| MX2009005413A (es) | Formas cristalinas del acido zoledronico. | |
| NZ609719A (en) | Pharmaceutical composition | |
| NZ595767A (en) | Composition for the treatment of prostate cancer | |
| SG152254A1 (en) | Contrast agents for myocardial perfusion imaging | |
| EP4578461A3 (en) | Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa | |
| NZ610247A (en) | Β-lactamase inhibitors and their use | |
| IL208279A (en) | History of Spiro (5.5) Undecan | |
| WO2012044783A8 (en) | Method of achieving a thymosin beta 4 concentration in a human patient | |
| MX340487B (es) | Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. | |
| PT2480232E (pt) | [4-(5-aminometil-fenil)-piperidin-1-il]-1h-indol-3-il]- metanonas dissubstituídas | |
| TW200501946A (en) | Pharmaceutical composition for the treatment of schizophrenia in a patient with overweight | |
| PT2454266E (pt) | Sal de citrato de 9e-15-(2-pirrolidin-1-il-etoxi)- 7,12,25-trioxa-19,21,24-triaza-tetraciclo- [18.3.1.1(2,5).1(14)18)]hexacosa- 1(24),2,4,9,14,16,18(26),20,22-nonaeno | |
| MY160005A (en) | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt | |
| MX2007005525A (es) | Tratamiento terapeutico de resorcion ose acelerada. | |
| MX2009006670A (es) | Composicion farmaceutica que usa el aliskiren y el avosentan. | |
| BRPI0512151A (pt) | solução concentrada de sal de sódio monoidratado do tenatoprazol, composição farmacêutica, utilização do sal de sódio monoidratado do tenatoprazol, processo de preparação do sal de sódio monoidratado do tenatoprazol, e composição para administração por via oral do sal de sódio monoidratado do tenatoprazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 28 OCT 2017 BY AJ PARK Effective date: 20140806 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 OCT 2018 BY COMPUTER PACKAGES INC Effective date: 20171003 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 OCT 2019 BY ANAQUA SERVICES Effective date: 20180919 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 OCT 2020 BY ANAQUA SERVICES Effective date: 20190918 |
|
| LAPS | Patent lapsed |